In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...
Tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total community benefits in 2022. According to ...
Rather than using their federal 340B drug discount savings to lower costs for patients, many hospitals reinvest their profits into acquiring independent clinics.
Could “TrumpRx” be the prescription for lower drug prices? President Trump announced a landmark deal with Pfizer to cut drug ...
12don MSN
Reform of federal drug discount program should target misaligned incentives, researchers say
The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.
Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain ...
The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...
Ryan Long, the co-author of a recent USC Schaeffer Center white paper on the 340B Drug Pricing Program, argues that meaningful reform requires shifting to a direct subsidy model based on need.
The 340B Drug Pricing Program was created to benefit low-income and uninsured Americans. Over time, it has morphed into a federal subsidy for hospitals in affluent areas at the expense ...
The nation's top pharmaceutical trade group is taking a legal swing at Rhode Island's new drug-pricing law.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results